MARKSANS.BO
Price:
$183.95
Market Cap:
$83.37B
Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Industry
Drug Manufacturers - General
IPO Date
Stock Exchange
BSE
Ticker
MARKSANS.BO
According to Marksans Pharma Limited’s latest financial reports and current stock price. The company's current ROE is 14.14%. This represents a change of 298.15% compared to the average of 3.55% of the last 4 quarters.
The mean historical ROE of Marksans Pharma Limited over the last ten years is 14.84%. The current 14.14% ROE has changed -4.71% with respect to the historical average. Over the past ten years (40 quarters), MARKSANS.BO's ROE was at its highest in in the March 2021 quarter at 8.97%. The ROE was at its lowest in in the March 2018 quarter at -1.46%.
Average
14.84%
Median
15.31%
Minimum
2.14%
Maximum
26.91%
Discovering the peaks and valleys of Marksans Pharma Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 226.74%
Maximum Annual ROE = 26.91%
Minimum Annual Increase = -87.61%
Minimum Annual ROE = 2.14%
| Year | ROE | Change |
|---|---|---|
| 2025 | 15.43% | 1.56% |
| 2024 | 15.19% | -0.45% |
| 2023 | 15.26% | -0.60% |
| 2022 | 15.35% | -42.95% |
| 2021 | 26.91% | 41.73% |
| 2020 | 18.99% | 28.04% |
| 2019 | 14.83% | 111.96% |
| 2018 | 7.00% | 226.74% |
| 2017 | 2.14% | -87.61% |
| 2016 | 17.28% | -40.01% |
The current ROE of Marksans Pharma Limited (MARKSANS.BO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
15.29%
5-year avg
17.63%
10-year avg
14.84%
Marksans Pharma Limited’s ROE is less than Strides Pharma Science Limited (15.72%), less than Strides Pharma Science Limited (15.72%), less than Aarti Pharmalabs Limited (13.85%), less than Aarti Pharmalabs Limited (13.85%), less than Sanofi India Limited (41.57%), less than Sanofi India Limited (41.57%), less than FDC Limited (9.71%), less than FDC Limited (9.71%), less than Yatharth Hospital & Trauma Care Services Limited (11.14%), less than Yatharth Hospital & Trauma Care Services Limited (11.14%),
| Company | ROE | Market cap |
|---|---|---|
| 15.72% | $80.99B | |
| 15.72% | $81.17B | |
| 13.85% | $65.45B | |
| 13.85% | $65.41B | |
| 41.57% | $99.82B | |
| 41.57% | $99.73B | |
| 9.71% | $67.41B | |
| 9.71% | $67.51B | |
| 11.14% | $66.19B | |
| 11.14% | $66.19B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Marksans Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Marksans Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Marksans Pharma Limited's ROE?
How is the ROE calculated for Marksans Pharma Limited (MARKSANS.BO)?
What is the highest ROE for Marksans Pharma Limited (MARKSANS.BO)?
What is the 3-year average ROE for Marksans Pharma Limited (MARKSANS.BO)?
What is the 5-year average ROE for Marksans Pharma Limited (MARKSANS.BO)?
How does the current ROE for Marksans Pharma Limited (MARKSANS.BO) compare to its historical average?